Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule.
DeBruyne
L
L
Department of Surgery, University of Michigan Medical Center Ann Arbor 48109, USA.
D000818:Animals; D002986:Clinical Trials as Topic; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006183:H-2 Antigens / Q000276:immunology / Q000627:therapeutic use; D015793:HLA-B7 Antigen / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D015395:Histocompatibility Antigens Class I / Q000235:genetics / Q000627:therapeutic use*; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008545:Melanoma / Q000276:immunology / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D009369:Neoplasms / Q000628:therapy*; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology / Q000378:metabolism*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D006183:H-2 Antigens; C078460:H-2K(sm1) antigen; D015793:HLA-B7 Antigen; D015395:Histocompatibility Antigens Class I; D016693:Receptors, Antigen, T-Cell, alpha-beta